Navigation Links
AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
Date:5/6/2013

-formulated tablets of ABT-450/r and ABT-267 are being used in the Phase 3 trials.

About the Hepatitis C Virus  Across the world, about 160 million people are chronically infected with hepatitis C.(2) Hepatitis C is an inflammation of the liver caused by an infection with the hepatitis C virus (HCV).(3)  HCV is transmitted when an infected person's blood enters the bloodstream of another person.(4)

For the hepatitis C virus, there are six major HCV genotypes (GT1-6).(5) Presently, there is no vaccine for the hepatitis C virus (HCV) infection.(5) Decision to treat is dependent on a number of factors such as the amount of liver damage present, other conditions the patient may have, amount of virus in the body, and viral genotype.(5) If treatment is needed, a hepatitis C infection is typically treated with a combination of antivirals.(5)

About AbbVie's HCV Development ProgramsAbbVie's HCV portfolio includes investigational medicines with three different mechanisms of action, including protease (ABT-450/r), polymerase (ABT-333) and NS5A (ABT-267) inhibitors, currently being studied in clinical trials. ABT-450 is being developed with low dose ritonavir which enhances the pharmacokinetic properties of ABT-450. The use of ritonavir 100mg with ABT-450 for the treatment of HCV is investigational.

ABT-450 was discovered during the course of a collaboration between AbbVie and Enanta Pharmaceuticals for HCV protease inhibitors and regimens that include protease inhibitors. ABT-450 is being developed by AbbVie for use in combination with AbbVie's other investigational medicines for the treatment of HCV. AbbVie is well-positioned to explore combinations and co-formulations of these medicines.

Ritonavir Use in the Treatment of HIVRitonavir is in a class of medicines called the HIV protease inhibitors. Ritonavir is used in combination with other anti-
'/>"/>

SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
2. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
3. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
4. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
5. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
6. Genocea Publishes Preclinical Data For Investigational Vaccine Candidate For HSV-2
7. Noven Announces FDA Advisory Committee Vote on Investigational Low-Dose Mesylate Salt of Paroxetine (LDMP) for Vasomotor Symptoms Associated with Menopause
8. Scioderms Investigational New Drug (IND) Application for SD-101 for Treatment of Epidermolysis Bullosa (EB) Allowed by the FDA
9. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
10. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
11. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 ... for Enterprise, having more than doubled its overseas sales ... PharmaGenesis today celebrates winning the Queen,s Award for Enterprise, ... is the world,s first HealthScience Communications consultancy, helping its ... of patient need. Having more than doubled its exports ...
(Date:4/21/2015)... According to a new ... Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, ... Residual Contamination, Adventitious Agents) - Global Forecast to ... Testing Market was valued at $1,758.69 Million in ... a CAGR of 12.23% to reach $3,130.85 Million ...
(Date:4/21/2015)... April 21, 2015 Legal cannabis ... to grow at a rapid pace over the next ... provide technology services for indoor/outdoor cultivators and new cannabis ... Surna Inc. (OTC: SRNA), Totally Hemp Crazy Inc. (OTC: ... (OTC: BVAP), 22 nd Century Group, Inc. (NYSE: ...
Breaking Medicine Technology:Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Biologics Safety Testing Market Worth $3,130.85 Million by 2019 2Biologics Safety Testing Market Worth $3,130.85 Million by 2019 3Biologics Safety Testing Market Worth $3,130.85 Million by 2019 4New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 2New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 3New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 4New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 5New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 6New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 7
(Date:4/21/2015)... PA (PRWEB) April 21, 2015 Grafika ... County commercial printer, Offset Impressions. , “We’re ... full line of printing capabilities and knowledgeable team members,” ... “This acquisition allows us to offer an ever wider ... the labeling, packaging, and specialty services we already offer. ...
(Date:4/21/2015)... Among parents of children with autism spectrum disorder, ... or poor, according to a study in the journal ... to the dentist can present many challenges for a ... smells, loud noises, and sharp tools; the unfamiliarity of ... whole process—not knowing what will happen and when it ...
(Date:4/21/2015)... (PRWEB) April 22, 2015 ... H1 2015” provides comparative analysis on the ... strengthens R&D pipelines by identifying new targets ... products. Complete report with TOC is available ... report also reviews key players involved in ...
(Date:4/21/2015)... 2015 “ ZeroWire ” was featured ... which takes a look at the latest and coolest ... a special reporter for NewsWatch and a technology expert, ... is a security system and lifestyle management hub. , ... over 2 million burglaries in 2010. It goes without ...
(Date:4/21/2015)... Chicago, IL (PRWEB) April 21, 2015 ... surgery provider in India for their ongoing commitment to ... Hyderabad strives to provide patients with the best ... to the skin, hair and body. , Executives at ... believes in the philosophy of — nothing about you, ...
Breaking Medicine News(10 mins):Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 2Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 3
... The Sarah Cannon Cancer Center (SCCC) at Centennial Medical Center ... in the battle against cancer. The Sarah Cannon Cancer Center ... to offer image-guided robotic stereotactic radiosurgery. , , ... on its promise to provide the highest quality, most advanced ...
... June 12 In light of the World Health Organization ... scale, Aon Corporation (NYSE: AOC ) today ... director of Aon Healthcare ,s alternative risk practice: , ... the H1N1 virus has achieved sustained community transmission in ...
... RNs Working at Six Major U.S. Hospitals Eligible for ... LAKE CITY, June 12 Western Governors University ... new program for nurses working at partner hospitals, the ... Cedar-Sinai Hospital, Tenet Healthcare, Hospital Corporation of America (HCA), ...
... solutions that address health care access, quality and cost , ... Affairs today unveiled a series of six studies examining ... papers were released at a forum presented by Health ... (CCNA) that featured a lively discussion among policy-makers, nursing leaders ...
... visionary act intended to have a transformative impact, former Texas ... unprecedented $100 million gift for UT Southwestern Medical Center. This ... was given through the Southwestern Medical Foundation, which supports the ... , "To those who may have questioned the prospects for ...
... are involved, study finds , FRIDAY, June 12 (HealthDay ... an incurable genetic disease isn,t worry enough, people with ... against by insurance companies, relatives and in social settings, ... colleagues at the University of British Columbia surveyed 233 ...
Cached Medicine News:Health News:New Treatment Option at The Sarah Cannon Cancer Center Provides Hope for Inoperable Tumors 2Health News:New Treatment Option at The Sarah Cannon Cancer Center Provides Hope for Inoperable Tumors 3Health News:No Time for Complacency in Pandemic Planning: Aon 2Health News:No Time for Complacency in Pandemic Planning: Aon 3Health News:Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 2Health News:Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners 3Health News:New Studies Show Nursing Workforce Critical to Success of Health Reform 2Health News:New Studies Show Nursing Workforce Critical to Success of Health Reform 3Health News:New Studies Show Nursing Workforce Critical to Success of Health Reform 4Health News:New Studies Show Nursing Workforce Critical to Success of Health Reform 5Health News:New Studies Show Nursing Workforce Critical to Success of Health Reform 6Health News:Former Gov. Bill Clements Makes Historic Gift to UT Southwestern With $100 Million 'Transformative' Contribution 2Health News:Former Gov. Bill Clements Makes Historic Gift to UT Southwestern With $100 Million 'Transformative' Contribution 3Health News:Former Gov. Bill Clements Makes Historic Gift to UT Southwestern With $100 Million 'Transformative' Contribution 4Health News:People With Huntington's Report Discrimination 2Health News:People With Huntington's Report Discrimination 3
... 1-step, hand-held, point-of-care device for the qualitative detection ... The TOX/See device can detect up to ... 3 to 8 minutes and requires only a ... individually packaged to maximize convenience and ease of ...
... is a whole blood formulation designed ... of the most popular glucose meters. ... using a control matrix that closely ... packaged in ready-to-use dropper vials with ...
... the laboratory to verify automatic pipets without purchasing ... Each PVS kit contains six vials of Receiver ... Solution. Using the pipet or dilutor to be ... kit is then returned to Streck for analysis ...
... Cyto-Chex BCT is a vacuum tube ... whole blood samples for immunophenotyping by flow ... maintains the integrity of the white blood ... up to seven days. Patient samples collected ...
Medicine Products: